From "fast-follow" to "first-in-class/best-in-class", Chinese R&D teams have repeatedly set new records in global clinical ...

As a leader in its category, Sinotau is probably hoping to follow in the footsteps of Hengrui Pharmaceuticals (1276.HK; ...

What you don’t know about ibuprofen, one of the world’s most popular painkillers, could well fill a book — and that book has ...

Stanford Medicine was forced to ration cancer drugs. A multi-disciplinary ethics committee was tasked with allocating a ...

Trastuzumab rezetecan has achieved breakthroughs in both efficacy and safety through pioneering molecular design from the ground up, a milestone made possible by Hengrui Pharmaceuticals' decade ...

NEW YORK – China's National Medical Products Administration approved Hengrui Pharma's antibody-drug conjugate trastuzumab rezetecan (SHR-A1811) for advanced or metastatic HER2-mutant non-small cell ...

Jiangsu Hengrui Pharmaceuticals, one of China’s largest drug makers, began trading on the Hong Kong stock exchange on Friday, marking a key step in its international expansion and giving a boost ...

© 2025 Fortune Media IP Limited. All Rights Reserved. Use of this site constitutes acceptance of our Terms of Use and Privacy Policy | CA Notice at Collection and ...